| Literature DB >> 32182064 |
Angela Bisio1, Anna M Schito2, Francesca Pedrelli1, Ombeline Danton3, Jakob K Reinhardt3, Giulio Poli4, Tiziano Tuccinardi4, Thomas Bürgi5, Francesco De Riccardis6, Mauro Giacomini7, Daniela Calzia1, Isabella Panfoli1, Gian Carlo Schito1, Matthias Hamburger3, Nunziatina De Tommasi8.
Abstract
A surface extract of the aerial parts of Salvia tingitana afforded a nor-sesterterpenoid (1) and eight new sesterterpenoids (2-̵9), along with five known sesterterpenoids, five labdane and one abietane diterpenoid, one sesquiterpenoid, and four flavonoids. The structures of the new compounds were established by 1D and 2D NMR spectroscopy, HRESIMS, and VCD data and Mosher's esters analysis. The antimicrobial activity of compounds was evaluated against 30 human pathogens including 27 clinical strains and three isolates of marine origin for their possible implications on human health. The methyl ester of salvileucolide (10), salvileucolide-6,23-lactone (11), sclareol (15), and manool (17) were the most active against Gram-positive bacteria. The compounds were also tested for the inhibition of ATP production in purified mammalian rod outer segments. Terpenoids 10, 11, 15, and 17 inhibited ATP production, while only 17 inhibited also ATP hydrolysis. Molecular modeling studies confirmed the capacity of 17 to interact with mammalian ATP synthase. A significant reduction of ATP production in the presence of 17 was observed in Enterococcus faecalis and E. faecium isolates.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32182064 PMCID: PMC7997632 DOI: 10.1021/acs.jnatprod.9b01024
Source DB: PubMed Journal: J Nat Prod ISSN: 0163-3864 Impact factor: 4.050